28 min listen
What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
ratings:
Length:
29 minutes
Released:
Jun 26, 2024
Format:
Podcast episode
Description
Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)? Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu
Released:
Jun 26, 2024
Format:
Podcast episode
Titles in the series (100)
What's New in NOACs in AF? Evaluating Emerging Evidence: Drs Patel, Coleman, and Camm review the latest real-world evidence for the use of NOACs in AF. --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/918743?src=mkm_podcast_addon_918743 by Keeping Current CME